Growth Hormone Releasing Hormone Reduces Circulating Markers of Immune Activation in Parallel with Effects on Hepatic Immune Pathways in Individuals with HIV-infection and Nonalcoholic Fatty Liver Disease.

This is a source-metadata record last found in a complete check on Sep 25, 2026. It is not a Pependium assessment of safety or effectiveness. Check the original sources for current details, corrections and full methods.

Source status: This saved record has not yet had a scheduled exact-ID status check. Check its original source links.

Study metadata

Study type: Original study
Study category (metadata hint): Human
Published: 2021-08-01
Authors: Stanley TL, Fourman LT, Wong LP, Sadreyev R, Billingsley JM, Feldpausch MN, Zheng I, Pan CS
Journal or registry: Not reported
Registry study design: Not reported
Registry enrollment: Not reported
Funding agencies: NIH HHS; NIAID NIH HHS; NCATS NIH HHS; National Institutes of Health; Nutrition Obesity Research Center at Harvard; NIDDK NIH HHS; National Cancer Institute; National Institute of Allergy and Infectious Diseases
Identifiers: DOI: 10.1093/cid/ciab019 · PMID: 33852720 · PMCID: PMC8366828
First found: Sep 25, 2026
Last found: Sep 25, 2026

Original sources

View at Europe PMC ↗